Published in Minerva Med on February 15, 1987
Duodenal metal-transporter (DMT-1, NRAMP-2) expression in patients with hereditary haemochromatosis. Lancet (1999) 2.68
Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest (2001) 2.49
Cardiac angiotensin II formation in the clinical course of heart failure and its relationship with left ventricular function. Circ Res (2001) 1.92
Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload. Gastroenterology (2001) 1.68
Evidence for the existence of a functional cardiac renin-angiotensin system in humans. Circulation (1996) 1.45
Silent ischemia in unstable angina is related to an altered cardiac norepinephrine handling. Circulation (1993) 1.44
Psoriatic arthritis in British and Italian patients: a comparative clinical, radiologic, and scintigraphic study. J Rheumatol (1999) 1.39
Heterogeneity of hemochromatosis in Italy. Gastroenterology (1998) 1.38
Hepatocyte growth factor/hepatopoietin A is expressed in fat-storing cells from rat liver but not myofibroblast-like cells derived from fat-storing cells. Hepatology (1992) 1.27
Increased cardiac sympathetic activity and insulin-like growth factor-I formation are associated with physiological hypertrophy in athletes. Circ Res (2001) 1.26
Inappropriately high iron regulatory protein activity in monocytes of patients with genetic hemochromatosis. Blood (1997) 1.17
Iron regulatory proteins in pathobiology. Biochem J (2000) 1.12
Cardiac growth factors in human hypertrophy. Relations with myocardial contractility and wall stress. Circ Res (1999) 1.08
Impaired iron transport activity of ferroportin 1 in hereditary iron overload. J Membr Biol (2005) 1.05
Wild-type HFE protein normalizes transferrin iron accumulation in macrophages from subjects with hereditary hemochromatosis. Blood (2000) 1.03
C/EBP-beta/LAP controls down-regulation of albumin gene transcription during liver regeneration. J Biol Chem (1996) 1.03
Iron removal therapy in porphyria cutanea tarda: phlebotomy versus slow subcutaneous desferrioxamine infusion. Br J Dermatol (1986) 1.02
Frequency and biochemical expression of C282Y/H63D hemochromatosis (HFE) gene mutations in the healthy adult population in Italy. J Hepatol (2001) 0.99
HJV gene mutations in European patients with juvenile hemochromatosis. Clin Genet (2005) 0.98
Serum ferritin in the assessment of liver iron overload and iron removal therapy in porphyria cutanea tarda. J Lab Clin Med (1986) 0.94
Excess iron into hepatocytes is required for activation of collagen type I gene during experimental siderosis. Gastroenterology (1994) 0.94
Cyclooxygenase and lipoxygenase metabolite synthesis by polymorphonuclear neutrophils: in vitro effect of dipyrone. Prostaglandins Leukot Essent Fatty Acids (1990) 0.92
Spatial and temporal dynamics of hepatic stellate cell activation during oxidant-stress-induced fibrogenesis. Am J Pathol (1998) 0.88
Platelet activation and platelet lipid composition in pulmonary cancer. Prostaglandins Leukot Essent Fatty Acids (1995) 0.88
The role of Ito cells in the biosynthesis of HGF-SF in the liver. EXS (1993) 0.87
Activity of dipyrone on intraplatelet arachidonic acid metabolism: an in vitro study. Pharmacol Res (1989) 0.86
Expression of messenger RNA for liver functions following 70% and 90% hepatectomy. J Hepatol (1996) 0.86
Lack of coordinate control of ferritin and transferrin receptor expression during rat liver regeneration. Hepatology (1998) 0.85
Effect of heparin-like compounds on the in vitro proliferation and protein synthesis of various cell types. Arzneimittelforschung (1989) 0.84
Coproporphyrin excretion in healthy newborn babies. J Pediatr Gastroenterol Nutr (1984) 0.84
Renal adaptation to stress: a possible role of endothelin release and prostaglandin modulation in the human subject. J Lab Clin Med (1997) 0.84
Human vascular renin-angiotensin system and its functional changes in relation to different sodium intakes. Hypertension (1998) 0.83
Excessive vasoconstriction after stress by the aging kidney: inadequate prostaglandin modulation of increased endothelin activity. J Lab Clin Med (1998) 0.83
Iron-induced oxidant stress leads to irreversible mitochondrial dysfunctions and fibrosis in the liver of chronic iron-dosed gerbils. The effect of silybin. J Bioenerg Biomembr (2000) 0.82
Nitric-oxide-mediated activation of iron-regulatory protein controls hepatic iron metabolism during acute inflammation. Eur J Biochem (1995) 0.82
Translational regulation of ferritin synthesis in rat liver. Effects of chronic dietary iron overload. Biochem J (1989) 0.81
Transferrin receptor gene expression during rat liver regeneration. Evidence for post-transcriptional regulation by iron regulatory factorB, a second iron-responsive element-binding protein. J Biol Chem (1994) 0.81
Trans-scapho-capitate perilunar dislocation of the carpus. Ital J Orthop Traumatol (1986) 0.81
Red blood cell lipid alterations in type II diabetes mellitus. Thromb Res (1989) 0.80
Prostaglandins in squamous cell carcinoma of the larynx: tumor and peritumor synthesis. Prostaglandins Leukot Essent Fatty Acids (1990) 0.80
Hereditary hemochromatosis masquerading as rheumatoid arthritis. Ann Ital Med Int (2001) 0.79
Selective amono acid solutions in hepatic encephalopathy treatment (a preliminary report). Ric Clin Lab (1981) 0.78
Activation of cardiac renin-angiotensin system in unstable angina. J Am Coll Cardiol (2001) 0.77
Gene expression of urea cycle enzymes following two-thirds partial hepatectomy in the rat. J Hepatol (1995) 0.77
3-Hydroxy-(4H)-benzopyran-4-ones as potential iron chelating agents in vivo. Bioorg Med Chem (2001) 0.76
G80S-linked ferroportin disease: the first clinical description in a Greek family. Blood Cells Mol Dis (2008) 0.76
Changes in thromboxane A2 generation and plasma lipid pattern in pseudomenopause induced by gonadotropin releasing hormone (GnRH) analogue buserelin. Prostaglandins Leukot Essent Fatty Acids (1991) 0.76
Clinical aspects of beta-thalassaemia minor. Panminerva Med (1983) 0.76
Hepatic stellate cells are not subjected to oxidant stress during iron-induced fibrogenesis in rodents. Hepatology (1998) 0.76
Basal promoter of the rat connexin 32 gene: identification and characterization of an essential element and its DNA-binding protein. Mol Cell Biol (1995) 0.75
Standard or branched-chain amino acid infusions as short-term nutritional support in liver cirrhosis? JPEN J Parenter Enteral Nutr (1985) 0.75
Iron, friend or foe? "Freedom" makes the difference. J Hepatol (2000) 0.75
Radioimmunoassay of thromboxane B2 in plasma: methodological modifications. Thromb Res (1988) 0.75
Hepatitis B virus infection in porphyria cutanea tarda. Liver (1986) 0.75
[Determination of serum ferritin in porphyria cutanea tarda. A reliable sign of hepatic siderosis]. Minerva Med (1984) 0.75
Paraneoplastic acute hepatitis. Acta Hepatosplenol (1969) 0.75
[Rational limitations of the therapy of liver cirrhosis and its update]. G Clin Med (1988) 0.75
Faecal and urinary coproporphyrin isomers in biliary atresia and neonatal hepatitis. Ric Clin Lab (1980) 0.75
[Preliminary observations and indications in the use of selective amino acid solutions in cirrhosis encephalopathy]. Clin Ter (1980) 0.75
[Hepatocytoma: new advances and new hypotheses]. G Clin Med (1990) 0.75
[Liver, this unknown organ (opinion of Prof. Mario Coppo)]. Minerva Gastroenterol (1975) 0.75
[Lipochrome hepatosis: its relationship to Dubin-Johnson's syndrome. Comparative studies of hepatocyte ultrastructure]. Minerva Med (1973) 0.75
[Satellite hepatitis and biliary cirrhosis]. Minerva Med (1972) 0.75
[Diagnosis of digestive diseases]. G Clin Med (1990) 0.75
Advances in the treatment of porphyria cutanea tarda. Effectiveness of slow subcutaneous desferrioxamine infusion. Liver (1984) 0.75
Porphyria cutanea tarda in beta-thalassemia trait carriers. Dermatologica (1984) 0.75
[The liver and alcohol. Results of our research]. Rev Med Chir Mal Foie (1971) 0.75
Zr and U determination at trace level in simulated deep groundwater by Q ICP-MS using extraction chromatography. Talanta (2012) 0.75
The functional potential of the rabbit fimbria. J Reprod Med (1984) 0.75
[A rare case of dysplasia epiphysealis osteochondromatosa (dysplasia epiphysealis hemimelica)]. Chir Organi Mov (1984) 0.75
[Diagnostic-prognostic significance of long-term (5-11 years) variations in serum GOT-GPT levels in the blood]. Minerva Med (1982) 0.75
High-performance liquid chromatographic differentiation of urinary free porphyrins. J Chromatogr (1982) 0.75
Ultrastructure of a two-cell human embryo fertilized in vivo. Ann N Y Acad Sci (1985) 0.75
[Definition of hepatopathic]. Minerva Med (1980) 0.75
[A difficult diagnosis: dyspepsia]. Minerva Med (1983) 0.75
An electron microscopic study of sperm penetration into the human egg investments. Anat Embryol (Berl) (1985) 0.75
Ultrastructure of a two-cell human embryo. Anat Embryol (Berl) (1987) 0.75
[Conjugated bile acids in cholestatic syndromes. Thin-layer chromatography and associated direct spectrofluorimetry]. Med Chir Dig (1977) 0.75
[Some known reasons for use of corticosteroids in the treatment of acute viral hepatitis]. Minerva Med (1975) 0.75
[That little-known organ, the liver]. Minerva Med (1971) 0.75
[Updating several aspects of liver cirrhosis]. G Clin Med (1987) 0.75
[Pathology of the upper digestive system: arguments on the diagnostic interview]. Recenti Prog Med (1988) 0.75
[Hereditary coproporphyria. A familial study]. Recenti Prog Med (1984) 0.75
Ultrastructure of the cumulus cell mass surrounding a human egg in the pronuclear stage. Anat Embryol (Berl) (1984) 0.75
Variations of serum glucose, insulin and neutral amino-acids during prolonged glucose infusion in liver cirrhosis. Med Chir Dig (1980) 0.75
Altered lipid composition and thromboxane A2 formation in platelets from patients affected by IIa hyperlipoproteinemia. Thromb Res (1988) 0.75
The Estes operation (transposition of one ovary to the uterine cavity): its results in the rabbit model. J In Vitro Fert Embryo Transf (1985) 0.75
Radiocopper (64Cu) incorporation into ceruloplasmin in chronic active hepatitis and in liver cirrhosis. J Nucl Med Allied Sci (1981) 0.75